Sentences with phrase «purchase price of the shares»

Part of the purchase price of the Shares was obtained through margin borrowing.

The aggregate purchase price of the Shares purchased by the Reporting Persons collectively was approximately $ 229 million (including commissions and premiums for options to purchase Shares).

The purchase price of the shares will be 85 % of the lower of the fair market value of our Class A common stock on the first trading day of each offering period or on the exercise date.

The purchase price of each Share will be (i) not less than the net asset...

The purchase price of each Share will be (i) not less than the net asset value per Share (the «NAV Per Share») of the Company's common stock (as determined in good faith by the board of directors of the Company or a committee thereof, in its sole discretion) immediately prior to the Expiration Date (as defined in the Offer to Purchase)(the date of repurchase) and (ii) not more than 2.5 % greater than the NAV Per Share as of such date, plus any unpaid dividends accrued through the expiration date of the Tender Offer.

The purchase price of the shares will be 85 % of the lower of the fair market value of our common stock on the first trading day of the offering period or on the last day of the offering period.

The purchase price of the shares will be 85 % of the lower of the fair market value of our common stock on the first trading day of each offering period or on the exercise date.

The purchase price of each Share will be (i) not less than the net asset... Read More... Read More

Determine FIF status - In order for the FIF taxation rules to apply to individuals, the cost price of offshore investments must exceed a prescribed threshold amount defined as the total purchase price of all shares.

It is only when you sell the mutual fund shares (back to the mutual fund company) that you have to pay taxes on the capital gains (if you sold for a higher price) or deduct the capital loss (if you sold for a lower price) than the purchase price of the shares.

With the Single Category method, you add up the purchase prices of all your shares and divide by the total.

As a value investor, you should know that your success will be fully dependent on the accuracy of your answers on simple questions like what is the real value of a specific company and if whether the actual intrinsic value is lesser than the total purchase price of the shares.

While the purchase price of the shares will not likely be identical for each transaction, it is also unlikely that they will differ significantly over such a short time frame.

Not exact matches

T. Rowe dropped Dropbox shares by 16 percent, meaning the current value of its holdings in that company is reportedly under water — 13 percent below the firm's original purchase price in 2012.

HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase additional shares, at a public offering price of $ 7.50 per share.

And the company could theoretically pull off such a purchase; the share price of Netflix has nosedived more than 60 % since its high in July, with a corresponding reduction in market cap.

This agreement provides for the purchase of the deceased partner's share of the business at a prearranged price.

When you purchase a broad swath of equities, say an S&P 500 index fund, the returns you can expect over the next decade or so comprise four building blocks: the starting dividend yield, projected growth in real earnings per share, expected inflation, and the expected change in «valuation» — that is, the expansion or contraction in the price / earnings (P / E) multiple.

And yet, buried in a footnote in Siebel's latest 10 - K filing is the fact that the company has granted options to employees to buy 9.8 million shares at an average purchase price of $ 6.46.

Though the IPO only gave Rovio half the market value the company had hoped for ($ 900 million ($ 1.1 billion) instead of its anticipated $ 2 billion), stock bounced back when a bank backing the IPO started purchasing shares to «stabilize» the price, according to Bloomberg.

Similarly, the volume simply converted based on the current share price is expected to reach a total of 2.37 million shares consisting of the existing 1.61 million ordinary shares (2.04 million before division) and 0.76 million shares to be additionally purchased and retired.

Meanwhile, in June, New York City's Blue Apron was forced to revise its initial share price, following news that Amazon intended to enter the sector just after its $ 13.7 billion purchase of Whole Foods.

As well, NAC has issued to Second Cup warrants to purchase 5,000,000 common shares of the company, at an exercise price of 91 cents per share.

Stock options allow employees to purchase shares in their company at a price fixed when the optionis granted (the grant price) for a defined number of years into the future.

Bellicum expects to grant the underwriters of the offering a 30 - day option to purchase up to an additional 1,050,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

One trade the SEC is looking at took place at 12:06 p.m. on that day, when there was a purchase of options with the rights to buy 200,000 shares of BlackBerry stock at a strike price of $ 10 a share, the person said.

Instead, if the investor is purchasing $ 5,000 worth of stock at a warrant - conversion price of $ 2,000, the company subtracts the cost of the conversion and actually turns over only $ 3,000 worth of shares to its investor.

HPE will pay $ 12.50 per share in cash, representing a net cash purchase price at closing of $ 1.0 billion.

The purchase gave another boost to the company's share price, which had already gone from $ 40 to over $ 60 in 2014, with a full year total stockholder return of 64 %.

There were also employee share options outstanding to purchase up to an additional 3.4 million shares, at a weighted average exercise price of $ 31.37 per share, 0.8 million of which were fully vested; equity - settled share appreciation rights (SARs) for 0.2 million shares, at a weighted average measurement price of $ 32.18, all of which, excluding SARs for approximately 1,000 shares, were fully vested; and restricted share units (RSUs) covering 13.0 million shares, of which RSUs to acquire 4.3 million shares were fully vested.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In addition to falling share prices and a lack of purchase offers, BlackBerry has also had to make staffing cuts.

Camber Capital Management, a hedge fund with an activist history, has purchased 5.7 million shares of Tenet Healthcare Corp., or a 5.7 % stake in the money - losing hospital chain.The emergence of Camber was disclosed Monday, just three days after Tenet's largest shareholder, Glenview Capital Management, resigned two Tenet board seats, citing irreconcilable differences with management and the board.Glenview Capital, which owns an 18 % stake in Tenet, gave notice Friday that it would no longer participate in a stand - still agreement that had prevented it from launching a proxy fight for control of the company.Tenet investors welcomed the Camber disclosure Monday, driving up Tenet's stock price to $ 2.18, or 15 %, to $ 16.63 as of 12:30 p.m. ET.Tenet is the nation's third - largest investor - owned

UNDERWRITING: $ 572,000 Multicom's lead underwriter, Laidlaw Equities Inc., in New York City, priced the securities at $ 6.50 a share and purchased 345,000 of the 1.1 million total shares from Multicom.

If you purchase shares of our common stock in this offering, you will experience immediate and substantial dilution of $ in the net tangible book value per share, assuming an initial public offering price of $ per share (the midpoint of the price range set forth on the front cover of this prospectus).

If the market price of our common stock declines significantly, you may be unable to resell your shares at or above your purchase price, if at all.

Should the deal's underwriters exercise an option to purchase up to 2.4 million additional shares, Ardagh said it could raise as much as $ 372.6 million (352.2 million euros) at the top of its price range.

However, Shares used to pay the exercise price or purchase price of an option or stock appreciation right or to satisfy tax withholding obligations relating to such awards do not become available for future issuance under the 2013 Plan.

If you are able to sell your shares of common stock, you will likely receive less than your purchase price.

From January 1, 2008 through December 31, 2010, the Registrant granted to its employees, consultants and other service providers options to purchase an aggregate of 12,566,833 shares of common stock under the Registrant's Amended and Restated 2003 Stock Incentive Plan, or the 2003 Plan, at exercise prices ranging from $ 1.50 to $ 14.46 per share, which includes options to purchase shares of common stock that were repriced on a one - for - one basis to $ 2.32 per share in February 2009.

5,800,200 shares of our Class B common stock issuable upon the exercise of options to purchase shares of our Class B common stock granted after June 30, 2015, with a weighted - average exercise price of $ 15.23 per share;

Therefore, if you purchase shares of our Class A common stock in this offering, you will experience immediate dilution of $ per share, the difference between the price per share you pay for our Class A common stock and its pro forma net tangible book value per share as of September 30, 2010, after giving effect to the issuance of shares of our Class A common stock in this offering.

From January 1, 2008 through December 31, 2010, the Registrant granted to certain executive officers, directors and other investors options and rights to purchase an aggregate of 8,196,662 shares of common stock under the 2003 Plan at exercise prices ranging from $ 2.00 to $ 6.20 per share, which includes options to purchase shares of common stock that were repriced on a one - for - one basis to $ 2.32 per share in February 2009.

The Compensation Committee believes that options to purchase shares of our common stock, with an exercise price equal to the market price of our common stock on the date of grant, are inherently performance - based and are a very effective tool to motivate our executives to build stockholder value and reinforce our position as a growth company.

a. I can do nothing and I'll be required to purchase 100 shares of said security at the strike price.

Shares used to pay the purchase price or satisfy tax withholding obligations of awards other than stock options or stock appreciation rights become available for future issuance under the 2013 Plan.

106,133,176 shares of our Class B common stock issuable upon the exercise of options to purchase shares of our Class B common stock outstanding as of September 30, 2015, with a weighted - average exercise price of $ 6.95 per share;

The founders of a startup generally purchase shares at the time of incorporating the company at a nominal price per share, such as $ 0.0001 per share, paid in cash, since at that time the company will have no operating history, few assets and thus little value.

That October, Buffett exercised all of its warrants to purchase 10.7 million shares of GE's common stock, a position valued at $ 264.76 million based on the closing price on the date the shares were delivered.

From July 2012 through September 2012, the Registrant sold an aggregate of 20,164,210 shares of its Series D convertible preferred stock to 21 accredited investors at a purchase price of approximately $ 11.014 per share, for an aggregate purchase price of approximately $ 222.1 million.